Key facts
- It has raised $1.0M; the latest was Seed Round ($1.0M) in Feb 2025.
- Notable investors include LaunchVic, Flying Fox Ventures, Australian Medical Angels, Peter Cronin, The George Institute for Global Health — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for GonGlobal
- ·The full record, as it builds
Funding rounds
No funding rounds for GonGlobal are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About GonGlobal
Operator of a reproductive health technology intended to improve the IVF patient experience and increase treatment success rates. The company offers non-invasive delivery of infertility drugs, enabling patients undergoing fertility treatments to access safer and more effective care.
- Sector
- Healthcare
- HQ
- Melbourne, Australia
- Founded
- 2023
- Employees
- 2
- Website
- gonglobal.com/
- Ownership
- Privately Held (backing)
GonGlobal doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in GonGlobal shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on GonGlobal in its N-PORT filings yet. We sweep new filings monthly.